American Herbal Products Association (AHPA) > News > AHPA Updates

AHPA Updates

  News   >   AHPA Updates

AHPA Updates

Updates on AHPA activities and resources delivered to your inbox. Subscribe today!

June 2019 AHPA Report: FDA-USDA at CBD Congress, NDI-GRAS Workshop, AHPA members and staff at USP, CFSAN, NIH and more

AHPA Members, Log in to access the AHPA Report

The June AHPA Report includes recent AHPA presentations at NIH, USP, CFSAN, plus legal and regulatory updates, recent AHPA news and advocacy and much more.

Sen. Wyden urges HHS-FDA to issue interim final rule for lawful use of CBD in food and dietary supplements

Sen. Wyden urges HHS-FDA to issue interim final rule for lawful use of CBD in food and dietary supplements

June 25, 2019: Sen. Wyden's request aligns with AHPA's hemp-CBD advocacy

Sen. Ron Wyden (D-OR), a co-author of the hemp provisions included in the 2018 Farm Bill, sent letters to Food and Drug Administration (FDA) Commissioner Ned Sharpless and Health & Human Services (HHS) Secretary Alex Azar urging the agencies to promptly create a regulatory pathway to use cannabidiol (CBD) as a food additive and as a dietary ingredient in dietary supplements.

AHPA President Michael McGuffin presents on CA regulations that impact the supplement industry at ACI Conference

AHPA provides several resources to help navigate CA regulations

American Herbal Products Association (AHPA) President Michael McGuffin discussed significant California regulations that impact the dietary supplement industry at the American Conference Institute's (ACI's) seventh annual Legal, Regulatory, and Compliance Forum on Dietary Supplements held in New York City June 18-20.

AHPA urges USTR to exempt herbal product ingredients from proposed China tariff increases

Herbal ingredients should be excluded from tariff increases because supplements and food play important roles in the health of U.S. consumers

The American Herbal Products Association (AHPA) urged the U.S. Trade Representative (USTR) to remove herbal product ingredients from a list of Chinese goods that would be subject to a 25 percent ad valorem duty under a recent USTR proposal to increase tariffs on an estimated $300 billion worth of Chinese imports.
More than 30 AHPA members and staff participate in the 2019 Day on the Hill

More than 30 AHPA members and staff participate in the 2019 Day on the Hill

June 11, 2019: AHPA partners with CRN, CHPA and UNPA to produce this unique advocacy opportunity

More than 30 AHPA member company executives—including company presidents, regulatory experts, and government relations executives—with a vested interest in legislative activity in Congress—flew in from across the nation, for a full day of networking and discussions with members of Congress and their staff. 

AHPA presents at 2019 NIH ODS Dietary Supplement Research Practicum

AHPA presents at 2019 NIH ODS Dietary Supplement Research Practicum

Dr. Zimmermann highlights industry actions to ensure safe and high-quality herbal supplements to medical professionals and researchers

AHPA Chief Information Analyst Merle Zimmermann, Ph.D. presented last week at the Mary Frances Picciano Dietary Supplement Research Practicum held by the Office of Dietary Supplements (ODS) at the National Institutes of Health (NIH) campus in Bethesda, MD.
AHPA President Michael McGuffin urges FDA to use existing authority to create legal pathway for CBD products

AHPA President Michael McGuffin urges FDA to use existing authority to create legal pathway for CBD products

May 31, 2020: McGuffin recommends FDA issue interim final rule with an accelerated effective date

American Herbal Products Association (AHPA) President Michael McGuffin urged the Food and Drug Administration (FDA) to use existing authority to quickly create a lawful pathway -- including considering issuing a interim final rule -- for marketing of cannabidiol (CBD)-containing supplements and foods at a public meeting held by FDA in Silver Spring, MD.

April-May 2019 AHPA Report: Sustainability for TCM, Annual Report, IADSA, CBD Guidance and more

AHPA Members, Log in to access the AHPA Report

The April-May AHPA Report includes strategies for TCM sustainability, legal and regulatory updates, recent AHPA news and advocacy and much more.

AHPA staff and members present at regulatory summit, USP, FDA-CFSAN and more

AHPA staff and members present at regulatory summit, USP, FDA-CFSAN and more

May 21, 2019: AHPA provides expertise in hemp-CBD, regulatory initiatives, pesticide residues, NDIs and food allergens

U.S. increases and proposes expansion of tariffs on Chinese imports

China announces additional tariffs on any plant mainly used as a spice

The U.S. Trade Representative (USTR) announced on May 9 that it increased tariffs on approximately $200 billion worth of Chinese imports initially identified in September 2018 from 10 percent to 25 percent.
RSS
First 891011121314151617 Last

2021 Annual Fund Sponsors

    

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.

          
Address: 8630 Fenton Street, Suite 918, Silver Spring, MD 20910
Phone: 301.588.1171
Email: ahpa@ahpa.org
Copyright 2021 by American Herbal Products Association (AHPA) | Privacy Statement | Terms Of Use